Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk

Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk

The purpose of this research is to better understand how benign breast diseases might lead to breast cancer, focusing on genetic factors and including a diverse range of participants to improve future diagnosis and treatment.

Inclusion Criteria:

• Female patients, ages 18 to 100 years
• Had a benign breast biopsy at Mayo Clinic between 2002-2022

Exclusion Criteria:

• All male patients
• Prior or concomitant diagnosis of BC
• Diagnosis of BC within six months of benign breast disease
• Denial of research authorization
• Concurrent or post-biopsy bilateral prophylactic mastectomy